PLGA-Lipid Hybrid Nanoparticles for Overcoming Paclitaxel Tolerance in Anoikis-Resistant Lung Cancer Cells

15 Sep 2023
0

PLGA-Lipid Hybrid Nanoparticles for Overcoming Paclitaxel Tolerance in Anoikis-Resistant Lung Cancer Cells

Pramual S, Lirdprapamongkol K, Atjanasuppat K, Chaisuriya P, Niamsiri N, Svasti J

Molecules. 2022;27(23):8295.

Tags

Share this

Related Posts

Khunnawutmanotham, N.; Chimnoi, N.; Saparpakorn, P.; Pungpo, P.; Louisirirotchanakul, S.; Hannongbua, S.; Techasakul, S. Novel 2- Chloro-8-Arylthiomethyldipyridodiazepinone Derivatives with Activity against HIV-1 Reverse Transcriptase. Molecule 2007, 20, 218-30.
Laohapaisan, P.; Lumyong, K.; Tummatorn, J.; Thongsornkleeb, C.; Chatwichien, J.; Supantanapong, N.; Ruchirawat, S. Ag(I)-Catalyzed/Acid-Mediated Cascade Cyclization of ortho-Alkynylaryl-1,3-dicarbonyls to Access Arylnaphthalenelactones and Furanonaphthol Libraries via Aryl-Disengagement. Chem. Asian J. 2021, 17, e202101212.

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)